Alerts will be sent to your verified email
Verify EmailKOPRAN
Kopran
|
Sequent Scientific
|
RPG Life Sciences
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
14.2 % | 3.75 % | 16.75 % |
5yr average Equity Multiplier
|
1.74 | 2.1 | 1.43 |
5yr Average Asset Turnover Ratio
|
0.95 | 0.87 | 1.3 |
5yr Avg Net Profit Margin
|
8.56 % | 2.4 % | 9.23 % |
Price to Book
|
2.85 | 4.88 | 6.85 |
P/E
|
31.15 | 0.0 | 29.3 |
5yr Avg Cash Conversion Cycle
|
104.91 Days | 61.25 Days | -46.65 Days |
Inventory Days
|
81.99 Days | 70.72 Days | 63.59 Days |
Days Receivable
|
94.82 Days | 84.11 Days | 23.17 Days |
Days Payable
|
82.13 Days | 118.6 Days | 141.25 Days |
5yr Average Interest Coverage Ratio
|
9.39 | 2.9 | 17.24 |
5yr Avg ROCE
|
19.06 % | 9.0 % | 23.6 % |
5yr Avg Operating Profit Margin
|
15.55 % | 10.83 % | 17.39 % |
5 yr average Debt to Equity
|
0.33 | 0.46 | 0.06 |
5yr CAGR Net Profit
|
2.54 % | n/a | 44.3 % |
5yr Average Return on Assets
|
8.15 % | 1.98 % | 11.89 % |
Shareholdings
|
|||
Promoter Holding
|
44.49 % | 52.79 % | 72.81 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.71 % | -1.07 % | 0.74 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.94 % | 2.48 % | 1.47 % |
Kopran
|
Sequent Scientific
|
RPG Life Sciences
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Dosage Form Break-Up
|
Dosage Form Break-Up
|
Dosage Form Break-Up
|
-
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
-
|